Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
Medtronic
QuintilesIMS
Accenture
Cipla
Queensland Health
Boehringer Ingelheim
Cerilliant

Generated: May 23, 2018

DrugPatentWatch Database Preview

RIMANTADINE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for RIMANTADINE HYDROCHLORIDE
Pharmacology for RIMANTADINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for RIMANTADINE HYDROCHLORIDE
Synonyms for RIMANTADINE HYDROCHLORIDE
.alpha.-Methyl-1-adamantanemethylamine hydrochloride
[1-(1-Adamantyl)ethyl]amine HCl
[1-(1-adamantyl)ethyl]amine hydrochloride
1-((3r,5r,7r)-adamantan-1-yl)ethanamine hydrochloride
1-(1-adamantyl)ethanamine hydrochloride
1-(1-adamantyl)ethanamine;hydrochloride
1-(1-ADAMANTYL)ETHYLAMINE HYDROCHLORIDE
1-(1-Adamantyl)ethylamine hydrochloride, 99%
1-(1-adamantyl)ethylaminehydrochloride
1-(1-Aminoethyl)adamantane hydrochloride
1-(ADAMANTAN-1-YL)ETHAN-1-AMINE HYDROCHLORIDE
1-(Adamantan-1-yl)ethanamine hydrochloride
1-(Adamantan-1-yl)ethylamine hydrochloride
1-(Tricyclo[3.3.1.13,7]dec-1-yl)ethanamine hydrochloride
1-adamantan-1-yl-ethylamine hydrochloride
1-ADAMANTANEMETHYLAMINE, alpha-METHYL-, HYDROCHLORIDE
1-Adamantanemethylamine, hydrochloride
1-adamantanylethylamine, chloride
1501-84-4
AB0011256
AC-8480
AC1L25AW
AC1Q398G
ACMC-209d41
ACT02687
Adamantane, 1-(1-aminoethyl)-, hydrochloride
AK162041
AKOS005267193
AKOS016034989
AKOS016340560
Algirem
alpha-methyl-1-adamantane-methanamine hydrochloride
alpha-Methyl-1-adamantanemethylamine hydrochloride
alpha-methyl-tricyclo[3.3.1.13,7]decane-1-methanamine hydrochloride (1:1)
alpha-Methyltricyclo(3.3.1.1(sup 3,7))decane-1-methanamine hydrochloride
AN-7966
ANW-21263
ARONIS24292
AS-12095
AT-3474
BB_SC-1154
C08094
C12H21N.HCl
C12H22ClN
CAS-1501-84-4
CCG-220606
CCG-41384
CHEBI:8865
CHEMBL1200355
CHEMBL535396
CPD000436311
CR-047
CS-2924
CTK3J1286
D0P2NN
DSSTox_CID_27790
DSSTox_GSID_47813
DSSTox_RID_82564
DTXSID1047813
EN300-08051
EXP 126
EXP-126
Flumadine
Flumadine (TN)
Flumadine hydrochloride
FT-0603562
HY-B0338A
I14-0456
J-006455
J05AC02
JP 61
KB-82632
KS-00000LR1
KS-5232
KSC491E8N
LS-15020
M-2014
MCULE-3886392620
Meradan
Meradane
MFCD00072023
MLS000069661
MLS000332981
MLS002548886
MolPort-000-142-042
MolPort-000-768-308
MolPort-016-638-353
MolPort-039-326-898
NC00674
NCGC00159491-02
NCGC00159491-04
NSC 206764
NSC-206764
NSC-759149
NSC206764
NSC759149
Oclovir
OZBDFBJXRJWNAV-UHFFFAOYSA-N
Pharmakon1600-01505460
PL026457
PubChem8738
PubChem8760
Q-201673
R0070
Remantadine hydrochloride
Rimantadine (hydrochloride)
Rimantadine HCL
Rimantadine hydrochloride (USAN)
Rimantadine hydrochloride [USAN]
Rimantadine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Rimantadine isomer 1
Roflual
RP04977
RTR-035768
SAM002264596
SBB003389
SC-00849
SC-01257
SCHEMBL40906
SMR000059215
SMR000436311
SR-01000631468-1
ST24037519
ST50508423
Tox21_111712
Tox21_111712_1
TR-035768
TRA0049787
Tricyclo(3.3.1.1(sup 3,7))-decane-1-methanamine, alpha-methyl-, hydrochloride
Tricyclo(3.3.1.13,7)decane-1-methanamine, alpha-methyl-, hydrochloride
Tricyclo(3.3.1.13,7)decane-1-methanamine, alpha-methyl-, hydrochloride (9CI)
VU0244476-5

US Patents and Regulatory Information for RIMANTADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth RIMANTADINE HYDROCHLORIDE rimantadine hydrochloride TABLET;ORAL 076375-001 Jan 14, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Labs RIMANTADINE HYDROCHLORIDE rimantadine hydrochloride TABLET;ORAL 076132-001 Aug 30, 2002 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Labs Inc RIMANTADINE HYDROCHLORIDE rimantadine hydrochloride TABLET;ORAL 075916-001 Nov 2, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
Cerilliant
Covington
Moodys
Boehringer Ingelheim
AstraZeneca
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.